Vimarsana
Biggest News Aggregation in the World

Page 5 - Jay Olson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jay Olson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jay Olson Today - Breaking & Trending Today

Scientists Have Invented a Simple New Test For Creativity, And You Can Try It Out - Vimarsana News

Scientists Have Invented a Simple New Test For Creativity, And You Can Try It Out

What makes one person more creative than another? Creativity is hard to define and perhaps even more difficult to measure, but scientists think they've come up with a remarkably simple way of assessing at least one aspect of it.

Smartphone addiction is worse for women, new study suggests - Vimarsana News

Smartphone addiction is worse for women, new study suggests

A landmark U of T study — featuring 50,000 participants — found that women reported more problematic smartphone use than men.

Competition cop Lina Khan's antitrust overreach is hurting U.S. competitiveness–and destroying billions of dollars in value - Vimarsana News

Competition cop Lina Khan's antitrust overreach is hurting U.S. competitiveness–and destroying billions of dollars in value

Antitrust overreach is hurting America's global competitiveness, with the FTC calculating industry concentration on a purely domestic basis.

Pfizer's Obesity Pill Disappointed. Biotech Rivals Are Rubbing Their Hands. - Vimarsana News

Pfizer's Obesity Pill Disappointed. Biotech Rivals Are Rubbing Their Hands.

Pfizer expects the market for new obesity pills to be $90 billion per year. Lilly, Novo, and many biotechs hope to claim chunks of it.

Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer — Here Are 2 Stocks to Take Advantage - Vimarsana News

Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer — Here Are 2 Stocks to Take Advantage

A key to success in the stock market is a touch of foresight. Not quite precognition, but an ability to spot and put together clues and trends, to discern the ‘next big thing’ before it hits. This is true in every stock sector, but today we’ll focus on biotech. The biotech firms have famously high product lead times, paired with equally high overhead expenses; it’s a combination that would make them unlikely investments, except that when a drug is approved, it can turn into a blockbuster. Succes

Source: yahoo.com